<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Plasma ET-1 Concentrations are Elevated in Patients with Hypertension -Meta-Analysis of Clinical Studies</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-05-30">May 30, 2017</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>Prof. Dr</roleName><forename type="first">Berthold</forename><surname>Hocher</surname></persName>
							<email>hocher@uni-potsdam.de</email>
							<affiliation key="aff2">
								<orgName type="department">Institute of Nutritional Science</orgName>
								<orgName type="institution" key="instit1">University of Potsdam</orgName>
								<orgName type="institution" key="instit2">Potsdam-Rehbrücke</orgName>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">Department of Embryology</orgName>
								<orgName type="institution">Medical School of the Jinan University</orgName>
								<address>
									<settlement>Guangzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department">IFLb</orgName>
								<orgName type="institution">Institut für Labormedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mei</forename><surname>Xu</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Traditional Chinese Medicine</orgName>
								<orgName type="department" key="dep2">Medical School</orgName>
								<orgName type="institution" key="instit1">Jinan University</orgName>
								<orgName type="institution" key="instit2">The First Affiliated Hospital of Jinan University</orgName>
								<orgName type="institution" key="instit3">Jinan University</orgName>
								<address>
									<settlement>Guangzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yong-Ping</forename><surname>Lu</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Institute of Nutritional Science</orgName>
								<orgName type="institution" key="instit1">University of Potsdam</orgName>
								<orgName type="institution" key="instit2">Potsdam-Rehbrücke</orgName>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department of Nephrology</orgName>
								<orgName type="institution">Charité -Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Campus Mitte</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ahmed</forename><forename type="middle">Abdallah</forename><surname>Hasan</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Institute of Nutritional Science</orgName>
								<orgName type="institution" key="instit1">University of Potsdam</orgName>
								<orgName type="institution" key="instit2">Potsdam-Rehbrücke</orgName>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Department of Biochemistry</orgName>
								<orgName type="department" key="dep2">Faculty of Pharmacy</orgName>
								<orgName type="institution">Zagazig University</orgName>
								<address>
									<country key="EG">Egypt</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Xu</forename><forename type="middle">/</forename><surname>Lu</surname></persName>
						</author>
						<author>
							<persName><forename type="first">/</forename><surname>Hasan</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Institute of Nutritional Science</orgName>
								<orgName type="institution">University of Potsdam</orgName>
								<address>
									<addrLine>Potsdam-Rehbrücke Arthur-Scheunert-Allee 114-116</addrLine>
									<postCode>14558</postCode>
									<settlement>Nuthetal, Potsdam, Homepage</settlement>
									<region>Germany</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Plasma ET-1 Concentrations are Elevated in Patients with Hypertension -Meta-Analysis of Clinical Studies</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-05-30">May 30, 2017</date>
						</imprint>
					</monogr>
					<idno type="MD5">1EB40B999ACCA81028C25F67D2AE9C68</idno>
					<idno type="DOI">10.1159/000477572</idno>
					<note type="submission">Accepted: May 08, 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:39+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND) (http://www.karger.com/Services/OpenAccessLicense).</s><s>Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Thirty-two years ago Hickey et al. <ref type="bibr" target="#b0">[1]</ref> found an endothelium-derived constricting factor by analyzing the supernatant of bovine aortic endothelial cells.</s><s>This factor was thought to be a peptide hormone, since trypsin abolished the vasoconstrictive property of this new factor <ref type="bibr" target="#b0">[1]</ref>.</s><s>The molecular structure of this endothelium-derived constricting factor was identified later by Yanagisawa et al. <ref type="bibr" target="#b1">[2]</ref> They named it endothelin, because it was isolated from the supernatant of porcine aortic endothelial cells.</s><s>Endothelin was a very strong vasoconstrictor.</s><s>It produces powerful, very long-lasting constrictions of a range of mammalian blood vessels in vitro including human arteries and veins.</s><s>It also causes long-lasting elevation of blood pressure when injected into rodents <ref type="bibr" target="#b1">[2]</ref>.</s><s>Because of these observation, scientists at this time were of the opinion that this peptidenowadays called endothelin-1 (ET-1), since there are two further endothelin isoforms that were discovered shortly after the initial discovery of ET-1 -plays a pivotal role in the pathogenesis of arterial hypertension <ref type="bibr" target="#b2">[3]</ref>.</s><s>It was thus an unexpected finding that ET-1 transgenic mice do not develop hypertension.</s><s>This was first shown by our group in Berlin, Germany <ref type="bibr" target="#b3">[4]</ref>.</s><s>ET-2 overexpressing rats likewise do not develop hypertension <ref type="bibr" target="#b4">[5]</ref>.</s><s>Both rat and mouse ET overexpression models develop renal intestinal fibrosis and glomerulosclerosis in a blood pressure independent manner <ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref>.</s><s>When going to the original publications, it was always noted that numerically the blood pressure was even somewhat lower in ET-1 transgenic mice as compared to their WT control counterparts.</s><s>The difference was numerically small and always detectable, When applying appreciate statistical testing of this hypothesis, however, statistical differences between blood pressure in ET-1 transgenic mice and their controls could not be verified in these individual studies.</s><s>To address this topic in more detail, we recently performed a meta-analsis about blood pressure in ET-1 transgenic mice studies reported in the past 20 years.</s><s>This meta-analysis provides robust evidence that global ET-1 overexpression in mice lowers blood pressure in an age-dependent manner.</s><s>Older ET-1+/+ mice had even a somewhat more pronounced reduction of blood pressure as compared to younger ET-1 transgenic mice when comparing these mice to their age-matched controls <ref type="bibr" target="#b10">[11]</ref>.</s><s>Given this findings in transgenic endothelin rodent models, the aim of the current study therefore was to perform a systematic review and meta-analysis of all published studies on ET-1 plasma concentrations in human patients with hypertension published so far.</s><s>We likewise analyzed data on age and body mass index with regard to blood ET-1 concentrations in humans.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Search strategy</head><p><s>Two authors screened for clinical studies in PubMed (Medline) and Google Scholar for studies relevant to the topic of ET-1 and hypertension in humans.</s><s>We included studies published between January 1, 1990 and February 28, 2017.</s><s>Searching keywords were "endothelin-1", and "hypertension".</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Inclusion and exclusion criteria</head><p><s>The first phases, we included all case control studies (CCSs) published in English.</s><s>Inclusion criteria were established as following: untreated essential hypertension or antihypertensive medication was discontinued for at least two weeks.</s><s>We checked all published papers fulfilling the above mentioned criteria.</s><s>The ET-1 concentration varied from 0.1 to 1000 pg/mL.</s><s>Most of the studies reported mean ET-1 concentration between 0.5 and 100 pg/mL.</s><s>We thus excluded studies reporting either extreme low or extreme high mean ET-1 concentrations in controls or hypertensive patients, because we assume quality issues of the used ET-1 assay systems in these studies reporting extreme values.</s><s>We also excluded duplicate publications, abstracts, and review articles.</s><s>Studies without comparison of hypertensive with normotensive subjects were likewise excluded.</s><s>We used the following definition for hypertension: systolic blood pressure &gt;140 mmHg and/or diastolic blood pressure 90 mmHg.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data extraction and quality assessment</head><p><s>Two authors selected relevant articles, abstracted data, and evaluated the quality of enrolled studies independently.</s><s>Questionable studies were resolved by discussion or consensus based on the views of a third reviewer.</s><s>We contacted the authors when we encountered information that was unclear or incomplete.</s></p><p><s>The following data were extracted from the included articles: ET-1 blood concentrations, age, BMI, SBP, DBP.</s><s>Data were given as mean ± SD.</s><s>When encountered data given as mean ± SEM, we calculated SD form SEM (the formula is SD = SEM × n 1/2 , n is the number of subjects in each group); When data ere given as mean and range (a,b), SD ≈ [(b-a) 2 + (a-2m+b) 2 /4] 1/2 /12 1/2 (n≤15) or SD ≈ (b-a)/4 (15&lt;n≤70) <ref type="bibr" target="#b11">[12]</ref>.</s><s>We unified the ET-1 concentration unit as pg/mL, 1 pg/mL ET-1 = 2.4919 × pmol/L = 2.4919 × fmol/mL, because reported ET-1 concentrations in the individual studies were not reported using the same units.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical processing</head><p><s>Statistical analyses were conducted by Review Manager Version 5.0 (Rev-Man 5.0) software, devised by Co-chrane Collaboration as described earlier <ref type="bibr" target="#b10">[11]</ref>.</s><s>Heterogeneity was assessed by P value and I 2 .</s><s>If there was no heterogeneity (P ≥ 0.1, I 2 ≤ 50%), we used the IV fixed-effects model.</s><s>If there was high heterogeneity (P &lt; 0.1, I 2 &gt; 50%), we chose IV random-effects model.</s><s>Binary outcomes were expressed as the risk ratio (RR) with 95%CI.</s><s>Continuous variables were expressed as mean difference (MD) with 95% CI.</s><s>In test for overall effect, the P ≤ 0.05 was considered statistically difference.</s></p><p><s>We performed also a subgroup analysis of the hypertensive patients.</s><s>In the 11 studies in the topic of ET-1 and hypertension, we conducted subgroups analysis according mean SBP in hypertensive group: subgroup 1, mean SBP &lt; 160mmHg; subgroup 2 mean SBP &gt; 160mmHg; subgroup 3 mean SBP unclear.</s><s>A comparable classification was used for diastolic blood subgroups: subgroup 1, mean DBP &lt; 100mmHg; subgroup 2 mean DBP &gt; 100mmHg; subgroup 3 mean DBP unclear.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Basic information</head><p><s>Based on the principle of Cochrane systematic reviews, and the inclusion and exclusion criteria of our meta-analysis, eleven <ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref> CCSs published studies included were in the present meta-analysis (450 patients in the hypertensive group, 328 controls in the normotensive group).</s><s>A more detailed description of the clinical characteristics of the included studies is given in Table <ref type="table">1</ref>.</s><s>Overall characteristics of included studies are given in Table <ref type="table">2</ref>.</s><s>The study design/flow chart is given in Figure <ref type="figure" target="#fig_0">1</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ET-1 and blood pressure</head><p><s>Eleven studies <ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref> reporting data on ET-1 and blood pressure could be included into the meta-analysis reporting data in patients without antihypertensive drug treatment.</s></p><p><s>The overall effect of the 11 studies <ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref> showed that hypertensive patients had higher ET-1 plasma concentrations than normotensive controls (mean difference 1.57 pg/mL, 95%CI [0.47~2.68],</s><s>P = 0.005, with high heterogeneity (P &lt; 0.00001, I 2 = 99%), Figure <ref type="figure" target="#fig_1">2</ref>).</s><s>A subgroups analysis according to mean SBP in the hypertensive group revealed that hypertensive patients with SBP &gt; 160mmHg hypertensive had higher ET-1 level than normotensive group (mean difference 2.03, 95%CI [0.10~3.97],</s><s>P = 0.04, with high heterogeneity (P &lt; 0.00001, I 2 = 95%), Figure <ref type="figure" target="#fig_1">2</ref>), whereas patient with mild hypertension (SBP between 140 and 160 mmHg) had similar ET-1 plasma concentrations as their normotensive controls (mean difference 0.70 pg/mL, 95%CI [-0.28~1.67],</s><s>P = 0.16, with high heterogeneity (P &lt; 0.00001, I 2 = 92%), Figure <ref type="figure" target="#fig_1">2</ref>).</s><s>between 90 and 100mmHg had similar ET-1 plasma concentrations as compared to normotensive controls (mean difference 0.45 pg/mL, 95%CI [-0.30~1.21],</s><s>P = 0.24, with high heterogeneity (P &lt; 0.00001, I 2 = 95%), Figure <ref type="figure" target="#fig_2">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>BMI</head><p><s>Six <ref type="bibr" target="#b15">[16]</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref> studies reported also data on BMI.</s><s>The overall effect of the six studies showed that hypertensive patients had higher BMI than normotensive controls (mean difference 0.71 kg/m 2 , 95%CI [0.36~1.06],</s><s>P &lt; 0.0001, with minimum heterogeneity (P = 0.16, I 2 = 37%), Figure <ref type="figure" target="#fig_3">4</ref> and Figure <ref type="figure" target="#fig_4">5</ref>).</s><s>A subgroup analysis according SBP in hypertensive group showed that patients with SBP between 140 and 160mmHg (mean difference 1.45 kg/m 2 , Table <ref type="table">2</ref>. Overall characteristics of the patients in the included studies</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Table 1. Characteristics of the included studies</head><p><s>A subgroups analysis according DBP showed that hypertensive patients with DBP &gt; 100mmHg had higher ET-1 plasma concentrations as compared to normotensive subjects: (mean difference 4.79 pg/mL, 95%CI [2.22~7.35],</s><s>P = 0.0003, with medium heterogeneity (P = 0.08, I 2 = 61%), Figure <ref type="figure" target="#fig_2">3</ref>); hypertensive patients with DBP 95%CI [0.68~1.95],</s><s>P &lt; 0.0001, with minimum heterogeneity (P = 0.98, I 2 = 0%), Figure <ref type="figure" target="#fig_4">5</ref>) as well as patients with DBP &gt; 100mmHg (mean difference 0.44 kg/m 2 , 95%CI [0.02~0.87],</s><s>P = 0.04, with medium heterogeneity (P = 0.09, I 2 = 66%), Figure <ref type="figure" target="#fig_4">5</ref>) had a higher BMI as compared to the normotensive controls.</s><s>95%CI [0.61~2.30],</s><s>P = 0.005, with minimum heterogeneity (P = 0.49, I 2 = 0%), Figure <ref type="figure" target="#fig_3">4</ref>) as well as patients with SBP &gt; 160mmHg (mean difference between groups: 0.55 kg/m 2 , 95%CI [0.16~0.94],</s><s>P = 0.005, with medium heterogeneity (P = 0.09, I 2 = 66%), Figure 4) had a higher BMI than normotensive group.</s><s>Similar findings were seen when using DBP to differentiate the hypertensive patients.</s><s>Patients with DBP between 90 and 100 mmHg (mean difference 1.31 kg/m 2 ,</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Key findings</head><p><s>The current meta-analysis in untreated patients with essential hypertension (450 hypertensive patients, 328 normotensive controls) revealed that ET-1 plasma concentrations were 42 % (= 1.57 pg/mL) higher in hypertensive patients as compared to the control patients.</s><s>The body mass index was slightly higher in the hypertensive patients.</s><s>These  finding were driven by patients having systolic blood pressure higher than 160 mmHg and/ or diastolic blood pressure higher than 100 mmHg.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study population</head><p><s>We identified 28 studies reporting data on ET-1 plasma levels in hypertensive patients (Figure <ref type="figure" target="#fig_0">1</ref>).</s><s>However, when applying the in-and exclusion criteria, only 11 studies were eligible for our meta-analysis due to various reasons such as incomplete reporting of data, reporting unrealistic high or low ET-1 plasma concentrations, duplication publications of studies and measurements of ET-1 concentration while the patients were treated with anti-hypertensive drugs.</s><s>We excluded studies where patients were on anti-hypertensive medication, since it is well known that there is a close interaction for example of the reninangiotensin-aldosterone system and the ET-1 system <ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref>.</s><s>RAAS blocking agents thus might influence ET-1 plasma concentrations independent of the actual blood pressure.</s><s>It was likewise shown that also beta blockers <ref type="bibr" target="#b28">[29,</ref><ref type="bibr" target="#b29">30]</ref> and calcium channel blockers <ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref> alter the paracrine ET-1 system.</s><s>The majority of the remaining studies reported plasma ET-1 concentrations in treatment naive hypertensive patients, see table 1.</s><s>We also included studies where the antihypertensive medication was stopped for at least two weeks.</s><s>Plasma ET-1 concentrations did not behave differently in treatment naive patients and patients where antihypertensive treatment was stopped, we thus analyzed both groups together.</s><s>It is of note that all hypertensive patients had a higher BMI as compared to the controls.</s><s>This is consistent with the statement in the analyzed studies that patients with essential -and not secondary forms of hypertension -were included only, since essential hypertension is associated frequently with an increased BMI.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ET-1 and blood pressure</head><p><s>A recent study showed that global ET-1 overexpression in mice lowers blood pressure in an age-dependent manner <ref type="bibr" target="#b10">[11]</ref>.</s><s>This fits well with the observation that a global heterozygous ET-1 knockout in mice causes hypertension (the complete knockout in homozygous ET-1 knockout mice is lethal due to craniofacial malformations <ref type="bibr" target="#b22">[23]</ref>).</s><s>This landmark study was recently confirmed by another independent group showing that a decrease in systemic ET-1 level of up to 35 % of that in the control mice causes hypertension <ref type="bibr" target="#b32">[33]</ref>.</s><s>Notably, in this model blood pressure could be normalized by epithelial sodium channel blockers, indicating that renal tubular sodium transport plays a key role in the pathogenesis of hypertension in these settings.</s><s>These animal studies showed that ET-1 has numerous independent effects on blood pressure regulation in vivo, it is involved in tubular water and salt excretion, promotes constriction of smooth muscle cells, modulates sympathetic nerve activity, and activates the liberation of nitric oxide via an ETB receptor-mediated pathway from endothelial cells.</s><s><ref type="bibr" target="#b2">[3,</ref><ref type="bibr" target="#b33">34,</ref><ref type="bibr" target="#b34">35]</ref>.</s><s>In mice, the net effect of these partially counteracting mechanisms on blood pressure is a slight reduction of blood pressure <ref type="bibr" target="#b10">[11]</ref>.</s><s>The current meta-analysis of human studies -on the other hand -showed that ET-1 plasma concentrations were 42 % higher in hypertensive patients as compared to the control patients.</s><s>The human ET-1 gene located on chromosome 6 (https://www.ncbi.nlm.nih.gov/gene/1906),</s><s>however, was not associated to human hypertension in any of the large scale genome wide association studies searching for hypertension associated gene loci (37.38.39).</s><s>The elevation of plasma ET-1 in the hypertensive patients seen in our meta-analysis thus rather reflects hypertension induced endothelial cell damage due to hypertension rather than the primary cause of hypertension.</s><s>This hypothesis is supported by the finding that the evasion of ET-1 was seen in the subgroup of patient with very high systolic and/or diastolic blood pressure (= patients with most likely blood pressure induced endothelial damage) , but not in the patients with milder forms of hypertension.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study limitations</head><p><s>The underlying reason for hypertension was not proven in most of the analyzed studies.</s><s>The authors simply assumed that they have analyzed patients with essential hypertension based on patient's medical records, but did not check the quality of the records in detail.</s><s>In addition, we had no systematic information's about the duration of hypertension in the analyzed studies in our meta-analysis.</s><s>Some patients were newly diagnosed or untreated essential hypertension, some other were hypertensive patients who stopped medications at least 2 weeks before study entry.</s><s>However, it is not clear whether this time in enough to eliminate the potential confounding effect of antihypertensive treatment.</s><s>It is thus not possible to state what was first hypertension followed by an elevation of ET-1 or elevated ET-1.</s><s>The renal tubular ET system is involved in water and salt transport and hence an increased salt reuptake in the kidney may contribute to the pathogeneses of hypertension.</s><s>Salt intake, however, was not measured in the studies included into the meta-analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p><s>This meta-analysis revealed that treatment naive hypertensive patients and patient who stopped blood pressure medication for at least two weeks do have slightly elevated plasma ET-1 concentration.</s><s>This finding is driven by these patients with high systolic/diastolic blood pressure.</s><s>Given that the ET-1 gene did not appear in any of the whole genome association studies searching for hypertension associated gene loci, it is very likely that the elevated plasma ET-1 concentrations in hypertensive patients are secondary to hypertension and may reflect endothelial cell damage.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 .</head><label>1</label><figDesc><div><p><s>Fig. 1.</s><s>Flow chart of the selection process defining the included sties in this meta-analysis.</s></p></div></figDesc><graphic coords="5,205.11,90.71,296.62,231.02" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2 .</head><label>2</label><figDesc><div><p><s>Fig. 2. Forrest blot showing the result of the meta-analysis of ET-1 plasma concentrations according to mean SBP in hypertensive and normotensive subjects.</s></p></div></figDesc><graphic coords="5,93.31,367.38,408.66,260.87" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 3 .</head><label>3</label><figDesc><div><p><s>Fig. 3. Forrest blot showing the result of the meta-analysis of ET-1 plasma concentrations according to mean DBP in hypertensive and normotensive subjects.</s></p></div></figDesc><graphic coords="6,93.54,90.71,408.19,257.95" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 4 .</head><label>4</label><figDesc><div><p><s>Fig. 4. Forrest blot showing the result of the meta-analysis of ET-1 plasma concentrations according to mean BMI in hypertensive and normotensive subjects when using SBP to define hypertensive patients.</s></p></div></figDesc><graphic coords="6,93.54,381.26,408.19,229.61" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig. 5 .</head><label>5</label><figDesc><div><p><s>Fig. 5. Forrest blot showing the result of the meta-analysis of ET-1 plasma concentrations according to mean BMI in hypertensive and normotensive subjects when using DBP to define hypertensive patients.</s></p></div></figDesc><graphic coords="7,93.54,90.71,408.19,226.77" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="4,93.54,104.49,408.19,371.74" type="bitmap" /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">© 2017 The Author(s). Published by S. Karger AG, Basel www.karger.com/kbr</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">DOI: 10.1159/000477572 Published online: May 30, 2017 © 2017 The Author(s). Published by S. Karger AG, Basel www.karger.com/kbr</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgment</head><p><s>The study was supported by a research grant from Bayer AG to Dr. B. Hocher.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Disclosure Statement</head><p><s>The authors of this manuscript state that they do not have any conflict of interests and nothing to disclose.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Characterization of a coronary vasoconstrictor produced by cultured endothelial cells</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Hickey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Rubanyi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Paul</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Highsmith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol</title>
		<imprint>
			<biblScope unit="volume">248</biblScope>
			<biblScope unit="page" from="C550" to="556" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">A novel potent vasoconstrictor peptide produced by vascular endothelial cells</title>
		<author>
			<persName><forename type="first">M</forename><surname>Yanagisawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kurihara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Tomobe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Mitsui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yazaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Goto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Masaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">332</biblScope>
			<biblScope unit="page" from="411" to="415" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Davenport</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Hyndman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Dhaun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Southan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Kohan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Pollock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Pollock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Webb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Maguire</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endothelin. Pharmacol Rev</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="357" to="418" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension</title>
		<author>
			<persName><forename type="first">B</forename><surname>Hocher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Thöne-Reineke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Rohmeiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Schmager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Slowinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Burst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Siegmund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Quertermous</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Neumayer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">D</forename><surname>Schleuning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Theuring</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="1380" to="1389" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Characterization of the renal phenotype of transgenic rats expressing the human endothelin-2 gene</title>
		<author>
			<persName><forename type="first">B</forename><surname>Hocher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Liefeldt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Thöne-Reineke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">D</forename><surname>Orzechowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Distler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Paul</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="196" to="201" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Renal damage and salt-dependent hypertension in aged transgenic mice overexpressing endothelin-1</title>
		<author>
			<persName><forename type="first">T</forename><surname>Shindo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kurihara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Maemura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kurihara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Ueda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kuwaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Ju</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ebihara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Nishimatsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Moriyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fukuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Akimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hirano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Morita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kumada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yazaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Nagai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kimura</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Med (Berl)</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="105" to="116" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Endothelin and tubulointerstitial renal disease</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Ong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Von Websky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hocher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Semin Nephrol</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="197" to="207" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Endothelin-1 Overexpression Improves Renal Function in eNOS Knockout Mice</title>
		<author>
			<persName><forename type="first">O</forename><surname>Tsuprykov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Chaykovska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kretschmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Stasch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Pfab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Krause-Relle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Reichetzeder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kalk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Adamski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hocher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Physiol Biochem</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="1474" to="1490" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Endothelin-1 overexpression restores diastolic function in eNOS knockout mice</title>
		<author>
			<persName><forename type="first">N</forename><surname>Vignon-Zellweger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Relle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kienlen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Alter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Seider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sharkovska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Heiden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kalk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Schwab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Albrecht-Küpper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Theuring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Stasch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hocher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hypertens</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="961" to="970" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Co-inhibition of Angiotensin II Receptor and Endothelin-1 Attenuates Renal Injury in Unilateral Ureteral Obstructed Mice</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">K</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Jeong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Na</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Choi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Blood Press Res</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="450" to="459" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Global Overexpression of ET-1 Decreases Blood Pressure -A Systematic Review and Meta-Analysis of ET-1 Transgenic Mice</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">P</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Tsuprykov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Vignon-Zellweger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Heiden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hocher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Blood Press Res</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="770" to="780" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range</title>
		<author>
			<persName><forename type="first">X</forename><surname>Wan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Med Res Methodol</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">135</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Application of monoclonal antibodies for endothelin to hypertensive research</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nakao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mukoyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Shirakami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Itoh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Arai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hosoda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Suga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Jougasaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Yoshihiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Shigeyuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Motohiko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Hiroo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="734" to="738" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Plasma immunoreactive endothelin in essential hypertension</title>
		<author>
			<persName><forename type="first">M</forename><surname>Kohno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yasunari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Murakawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yokokawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Horio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fukui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Takeda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Med</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="614" to="618" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Urinary excretion rate of endothelin-1 in patients with essentialhypertension and salt sensitivity</title>
		<author>
			<persName><forename type="first">A</forename><surname>Hoffman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Grossman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Goldstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Gill</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Keiser</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="556" to="560" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Elevated endothelin-1 plasma concentration in patients with essential hypertension</title>
		<author>
			<persName><forename type="first">A</forename><surname>Januszewicz</surname></persName>
		</author>
		<author>
			<persName><surname>Lapińskim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Symonides</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Dabrowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kuch-Wocial</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Trzepla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Ignatowska-Switalska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wocial</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chodakowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Januszewicz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cardiovasc Risk</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="81" to="85" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Increased basal concentrations of plasma endothelin in borderlinehypertension</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Lemne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Lundeberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Theodorsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>De Faire</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hypertens</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="1069" to="1074" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Central obesity and hypertension: the role of plasma endothelin</title>
		<author>
			<persName><forename type="first">G</forename><surname>Parrinello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Scaglione</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pinto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Corrao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cecala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Di</forename><surname>Silvestre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Amato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Licata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Licata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Hypertens</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="1186" to="1191" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Changes of plasma endothelin and growth factor levels, and of left ventricular mass, after chronic AT1-receptor blockade in humanhypertension</title>
		<author>
			<persName><forename type="first">S</forename><surname>Cottone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vadalà</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Vella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Nardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mulé</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Contorno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Riccobene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Cerasola</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Hypertens</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="548" to="553" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Circadian rhythm of urinary endothelin-1 excretion in mildly pertensive patients</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename><surname>Hwang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Hsieh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Tsai</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Hypertens</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1344" to="1351" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Plasma levels of soluble cellular adhesion molecules in patientswith arterial hypertension. Correlations with plasma endothelin-1</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Parissis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">F</forename><surname>Venetsanou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Mentzikof</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Kalantzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Georgopoulou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Chrisopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Karas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Intern Med</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="350" to="356" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Interactions beteween sympathetic nervous system andendogenous endothelin in patients with essential hypertension</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Bruno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Sudano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ghiadoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Masi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Taddei</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="78" to="84" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<author>
			<persName><forename type="first">X</forename><surname>Gu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Gu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Harding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Inverse Correlation Between Plasma Adropin and ET-1 Levels inEssential Hypertension: A Cross-Sectional Study</title>
				<imprint>
			<date type="published" when="2015">2015</date>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page">e1712</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Endothelin system-dependent cardiac remodeling in renovascular hypertension</title>
		<author>
			<persName><forename type="first">B</forename><surname>Hocher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>George</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rebstock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bauch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schwarz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Neumayer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bauer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="816" to="822" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">ETA receptor blockade induces fibrosis of the clipped kidney in two-kidney-one-clip renovascular hypertensive rats</title>
		<author>
			<persName><forename type="first">B</forename><surname>Hocher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>George</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Diekmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rebstock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schwarz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Thöne-Reineke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Neumayer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bauer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hypertens</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="1807" to="1814" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Differential modulation of the renal and myocardial endothelin system by angiotensin II in Vivo. Effects of chronic selective ETA receptor blockade</title>
		<author>
			<persName><forename type="first">M</forename><surname>Barton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">V</forename><surname>Uscio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Moreau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Lüscher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cardiovasc Pharmacol</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="S265" to="268" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptors for endothelin regulation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Barton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">V</forename><surname>Uscio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Moreau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Lüscher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">238</biblScope>
			<biblScope unit="page" from="861" to="865" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Angiotensin II increases tissue endothelin and induces vascular hypertrophy: reversal by ET(A)-receptor antagonist</title>
		<author>
			<persName><forename type="first">P</forename><surname>Moreau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">V</forename><surname>Uscio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Takase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Barton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Lüscher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="1593" to="1597" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Effects of nebivolol on endothelial gene expression during oxidative stress in human umbilical vein endothelial cells</title>
		<author>
			<persName><forename type="first">U</forename><surname>Garbin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Fratta</forename><surname>Pasini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Stranieri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Manfro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mozzini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Boccioletti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Pasini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cominacini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Evangelista</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cominacini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mediators Inflamm</title>
		<imprint>
			<biblScope unit="page">367590</biblScope>
			<date type="published" when="2008">2008. 2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Beta-blockers of the third generation inhibit endothelin-1 liberation, mRNA production and proliferation of human coronary smooth muscle and endothelial cells</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Brehm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bertsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Von Fallois</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Wolf</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cardiovasc Pharmacol</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="S401" to="403" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Földes-Filep E: Effects of calcium antagonists on endothelin-1-induced myocardial ischaemia and oedema in the rat</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Filep</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Skrobik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fournier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="893" to="900" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Prostacyclin synthesis elicited by endothelin-1 in rat aorta is mediated by an ETA receptor via influx of calcium and is independent of protein kinase C</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Wright</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">U</forename><surname>Malik</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1035" to="1040" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Endothelin-1 critically influences cardiac function via superoxide-MMP9 cascade</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Hathaway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Grant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Hagaman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hiller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">J</forename><surname>Madden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Bagnell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rojas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Smithies</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kakoki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="5141" to="5146" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">The paracrine endothelin system; pathophysiology and implications in clinical medicine</title>
		<author>
			<persName><forename type="first">B</forename><surname>Hocher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Thöne-Reineke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Raschack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Neumayer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Clin Chem Clin Biochem</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="175" to="189" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Pathophysiology of the endothelin system -lessons from genetically manipulated animal models</title>
		<author>
			<persName><forename type="first">K</forename><surname>Von Websky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Heiden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Pfab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hocher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Med Res</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="1" to="6" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
